Daniel Christoph Amberger

6PUBLICATIONS
8CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 15, 2026
Comparative Evaluation of Kit-M (GM-CSF and PGE-1) and Kit-I (GM-CSF and Picibanil) for the Generation of DCs/DCleus and Their Impact on Subsequent Antileukemic Immune Cell Activation Ex Vivo.

|Mar 14, 2026
Modulation of Leukemic Blasts into Dendritic Cells (DCleu) and Their Role in Predicting Survival in Patients with AML and MDS.

Daniel Christoph Amberger, Zuzana Fischer, Diana Deen

|Feb 26, 2025
Leukemia-Derived Dendritic Cells Induce Anti-Leukemic Effects Ex Vivo in AML Independently of Patients' Clinical and Biological Features.

Lara Kristina Klauer, Hazal Aslan Rejeski, Selda Ugur

|Jan 08, 2025
In Vivo Induction of Leukemia-Specific Adaptive and Innate Immune Cells by Treatment of AML-Diseased Rats and Therapy-Refractory AML Patients with Blast Modulating Response Modifiers.

Michael Atzler, Tobias Baudrexler, Daniel Christoph Amberger

|Jan 08, 2023
Dendritic Cell-Triggered Immune Activation Goes along with Provision of (Leukemia-Specific) Integrin Beta 7-Expressing Immune Cells and Improved Antileukemic Processes.

Elias Rackl, Lin Li, Lara Kristina Klauer

|Aug 12, 2022
Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations.

Christoph Schwepcke, Lara Kristina Klauer, Diana Deen

Pageof 1

Frequent Collaborators

4 joint publications

Andreas Rank

3 joint publications

Lara Kristina Klauer

1 joint publications

Lin Li

1 joint publications

Corinna L Seidel